SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-17-000132
Filing Date
2017-04-27
Accepted
2017-04-27 11:29:01
Documents
75
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmy-20170331x10q.htm 10-Q 1255725
2 COMPUTATION OF EARNINGS TO FIXED CHARGES exhibit12ratioofearningsto.htm EX-12 73904
3 EXHIBIT 31.A bmyex31a_20170331.htm EX-31.A 11612
4 EXHIBIT 31.B bmyex31b_20170331.htm EX-31.B 11825
5 EXHIBIT 32.A bmyex32a_20170331.htm EX-32.A 3936
6 EXHIBIT 32.B bmyex32b_20170331.htm EX-32.B 3936
  Complete submission text file 0000014272-17-000132.txt   7773726

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bmy-20170331.xml EX-101.INS 1793776
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20170331.xsd EX-101.SCH 57076
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20170331_cal.xml EX-101.CAL 117821
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20170331_def.xml EX-101.DEF 240608
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20170331_lab.xml EX-101.LAB 781357
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20170331_pre.xml EX-101.PRE 417163
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 17787070
SIC: 2834 Pharmaceutical Preparations